Future research will focus on gene function verification, multi-model verification, and in-depth clarification of the molecular mechanism underlying the GAL-ADORA2A interaction, thereby laying a more solid and comprehensive theoretical and practical foundation for PBC treatment. Here, ADORA2A is linked to primary biliary cholangitis.